Moreover, the VEGFRs and PDGFRβ inhibitor vorolanib diminishes STAT3 and NF-kB phosphorylation in a dose-dependent manner in NSCLC cells and xenograft mice (49). Here, NFKB1 is linked to non-small cell lung carcinoma.